CTEV vs EW · rev $930.6M vs P/E 47, rev $1.39B
Claritev Corporation (CTEV) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Claritev Corporation (CTEV) is a health information services company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CTEV revenue for 2024-12-31 was $930.6M. Net income was -$1.65B. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. CTEV currently screens at market cap $440.5M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CTEV currently screens at market cap $440.5M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CTEV and EW stock pages for the full models.
Not investment advice.